NCT03255577View on ClinicalTrials.gov

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

August 17, 2017

Primary Completion Date

June 15, 2026

Study Completion Date

August 30, 2026

Conditions
Breast CancerLocally Advanced Breast Cancer
Interventions
PROCEDURE

Sentinel Lymph Node Biopsy (SLNB)

Sentinel Lymph Node Biopsy Patients with locally advanced breast cancer will undergo SLNB with dual tracer mapping followed by completion axillary lymph node dissection.

Trial Locations (8)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10604

RECRUITING

Memorial Sloan Kettering Westchester, Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Consent only and Follow Up), Uniondale

11725

RECRUITING

Memorial Sloan Kettering Commack, Commack

33143

RECRUITING

BAPTIST ALLIANCE - MCI (Data Collection Only), Miami

07920

RECRUITING

Memorial Sloan Kettering at Basking Ridge (Consent and Follow Up), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth, Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Consent only and Follow Up), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER